Kocom Co., Ltd. (KOSDAQ:015710)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Aug 8, 2025	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Market Capitalization	67,969	108,716	111,870	113,198	108,716	112,036
Market Cap Growth	13.40%	-2.82%	-1.17%	4.12%	-2.96%	-14.99%
Enterprise Value	49,995	94,717	93,350	85,144	78,316	91,838
Last Close Price	4095.00	6349.88	6534.07	6503.72	6101.74	6133.51
PE Ratio	17.03	-	25.95	15.55	13.23	8.07
PS Ratio	0.65	1.14	1.21	0.95	0.81	0.69
PB Ratio	0.55	0.90	0.90	0.92	0.92	0.99
P/TBV Ratio	0.56	0.92	0.91	0.94	0.93	1.00
P/FCF Ratio	167.20	-	-	24.96	8.06	8.63
P/OCF Ratio	79.08	-	-	9.37	7.18	7.54
EV/Sales Ratio	0.48	0.99	1.01	0.72	0.59	0.56
EV/EBITDA Ratio	9.93	-	17.95	7.05	5.31	5.05
EV/EBIT Ratio	15.70	-	23.86	7.84	5.82	5.39
EV/FCF Ratio	122.99	-	-	18.77	5.81	7.08
Debt / Equity Ratio	0.03	0.04	0.10	0.02	-	-
Debt / EBITDA Ratio	0.65	-	2.34	0.16	-	-
Debt / FCF Ratio	8.02	-	-	0.43	-	-
Asset Turnover	0.71	0.62	0.60	0.80	0.91	1.18
Inventory Turnover	4.34	4.45	4.95	7.76	7.82	8.46
Quick Ratio	2.24	2.06	2.79	2.93	2.85	2.19
Current Ratio	3.45	3.00	3.84	3.57	3.37	2.78
Return on Equity (ROE)	3.28%	-2.16%	3.49%	6.06%	7.12%	12.88%
Return on Assets (ROA)	1.35%	-0.93%	1.58%	4.55%	5.70%	7.71%
Return on Capital (ROIC)	1.58%	-1.09%	1.87%	5.60%	7.28%	9.90%
Return on Capital Employed (ROCE)	2.40%	-	2.80%	8.30%	10.70%	14.10%
Earnings Yield	5.87%	-2.43%	3.85%	6.43%	7.56%	12.38%
FCF Yield	0.60%	-2.48%	-15.95%	4.01%	12.40%	11.58%
Dividend Yield	1.71%	-	-	2.38%	2.62%	3.18%
Payout Ratio	-	-	59.67%	36.49%	39.38%	19.74%
Buyback Yield / Dilution	-	-	-	-	-	0.02%
Total Shareholder Return	1.71%	-	-	2.38%	2.62%	3.20%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.